Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bactiguard Holding ABSTU:5JE +3.69%56 Days Payable is 125.06 as of Jun. 2026, which is 7% below its 10-year median of 133.94. GuruFocus rates STU:5JE with a GF Score™ of 56/100 and a GF Value™ of €2.68 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Bactiguard Holding AB ranks better than 86.04% on this metric.
The historical rank and industry rank for Bactiguard Holding AB's Days Payable or its related term are showing as below:
STU:5JE'
s Days Payable Range Over the Past 10 Years
Min: 84.33 Med: 133.94 Max: 272.36
Current: 220.77
During the past 13 years, Bactiguard Holding AB's highest Days Payable was 272.36. The lowest was 84.33. And the median was 133.94.
STU:5JE's Days Payable is ranked better than 86.04% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs STU:5JE: 220.77
Bactiguard Holding AB Days Payable Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Bactiguard Holding AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bactiguard Holding AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB (STU:5JE) has a Days Payable of 125.06 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bactiguard Holding AB and its competitors. This is near median its historical median of 133.94. Over the past decade, Bactiguard Holding AB's Days Payable has ranged from 84.33 to 272.36. According to the industry distribution chart, Bactiguard Holding AB ranks #111 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 14%.
Is Bactiguard Holding AB's Days Payable too high?
Bactiguard Holding AB's current Days Payable of 125.06 is near median its 10-year median of 133.94. Over the past 10 years, this metric has ranged from a low of 84.33 to a high of 272.36. The Medical Devices & Instruments industry median Days Payable is 67.87. Bactiguard Holding AB's value of 125.06 is 84.3% above this industry median. Based on the distribution chart, Bactiguard Holding AB ranks #111 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #111 out of 795 companies for Days Payable. This places Bactiguard Holding AB in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Bactiguard Holding AB's value of 125.06 is 84.3% above this benchmark. Historically, Bactiguard Holding AB's own Days Payable has ranged from 84.33 to 272.36 over the past decade. While the company's 10-year median is 133.94 vs. the industry median of 67.87, Bactiguard Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bactiguard Holding AB's current Days Payable of 125.06 is 84.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current Days Payable is 125.06, which is near median its own 10-year median of 133.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bactiguard Holding AB (STU:5JE) is currently considered Possible Value Trap. The stock's GF Value™ is €2.68, compared to a current price of €1.41 — trading 47.6% below its estimated fair value. The current Days Payable is 125.06, which is near median its 10-year median of 133.94 and 84.3% above the Medical Devices & Instruments industry median of 67.87. Bactiguard Holding AB's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bactiguard Holding AB (STU:5JE), the current Days Payable is 125.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (STU:5JE) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of €1.41 is trading 47.6% below its estimated GF Value™ of €2.68.
GuruFocus considers Bactiguard Holding AB to be Possible Value Trap.
Key valuation signals for STU:5JE:
Days Payable: 125.06 (near median its 10-year median of 133.94)
GF Value™: €2.68 vs. price of €1.41 (47.6% below fair value)
Industry Position: 84.3% above the Medical Devices & Instruments median (#111 of 795)
No single metric tells the full story. See the STU:5JE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
56GF Score
Get the complete analysis for STU:5JE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:5JE has been successfully added to your 
